Rutgers and Stanford scientists develop novel way to inject healthy human nerve cells into the brain
Scientists at Rutgers and Stanford universities have created a new technology that could someday help treat Parkinson’s disease and other devastating brain-related conditions that affect millions of people.
“If you can transplant cells in a way that mimics how these cells are already configured in the brain, then you’re one step closer to getting the brain to communicate with the cells that you’re now transplanting,” said Moghe, research director for the School of Engineering/Health Sciences Partnerships at Rutgers. “In this work, we’ve done that by providing cues for neurons to rapidly network in 3-D.”
Neurons, or nerve cells, are critical for human health and functioning. Human brains have about 100 billion neurons, which serve as messengers that transmit signals from the body to the brain and vice versa.
Moghe said a 3-D scaffold, developed by the scientists, consists of tiny polymer fibers. Hundreds of neurons attach to the fibers and branch out, sending their signals. Scaffolds are about 100 micrometers wide – roughly the width of a human hair.
“We take a whole bunch of these islands and then we inject them into the brain of the mouse,” he said. “These neurons that are transplanted into the brain actually survived quite miraculously well. In fact, they survived so much better than the gold standard in the field.”
Indeed, the scaffold technology results in a 100-fold increase in cell survival over other methods, Moghe said.
And that may eventually help people suffering from Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, Alzheimer’s disease, spinal cord and traumatic brain injuries, and concussions, he said.
These diseases and conditions often arise from the loss of brain cells. Parkinson’s disease, for example, is caused by the loss of brain cells that produce dopamine, a key neurotransmitter. Brain cell loss can lead to trembling in the hands, arms, legs, jaw and face; rigidity, or stiffness of the limbs and trunk; slowness of movement; and impaired balance and coordination, according to the National Institutes of Health.
The next step would be to further improve the scaffold biomaterials, allowing scientists to increase the number of implanted neurons in the brain. “The more neurons we can transplant, the more therapeutic benefits you can bring to the disease,” Moghe said. “We want to try to stuff as many neurons as we can in as little space as we can.”
The idea is to “create a very dense circuitry of neurons that is not only highly functioning but also better controlled,” he said, adding that testing of mice with Parkinson’s disease is underway to see if they improve or recover from the illness.
Eventually, with continued progress, the researchers could perform studies in people. Moghe estimated that it would take 10 to 20 years to test the technology in humans.
Developing the scaffold technology and reprogramming the stem cells in the scaffolds was “very hard team work,” he said. “It took many years to get here, so there was a lot of sweat and toil.”
The Latest on: Stem cell bioengineering
via Google News
The Latest on: Stem cell bioengineering
- Diabetes in mice cured rapidly using human stem cell strategyon February 25, 2020 at 8:12 am
Millman, Ph.D., an assistant professor of medicine and of biomedical engineering at Washington University. Several years ago, the same researchers discovered how to convert human stem cells into ...
- Diabetes in mice cured using human stem cell strategy: studyon February 24, 2020 at 4:00 pm
is that you also produce other cells that you don't want," said principal investigator Jeffrey R. Millman, an assistant professor of medicine and of biomedical engineering at Washington University.
- Researchers develop label-free microscopic techniques to visualize extracellular vesicleson February 23, 2020 at 11:15 am
The imaging system allows us to capture all this information simultaneously, allowing us to see many more details about the tissue, cells, and their functions than the current ways of imaging," said ...
- Bioengineers create light-controllable CAR T cells for cancer immunotherapyon February 19, 2020 at 10:57 pm
Thus, there is a great need to engineer CAR T cells that can be controlled with high precision in space and time." Peter Yingxiao Wang, professor of bioengineering at the UC San Diego Jacobs School of ...
- Engineering light-controllable CAR T cells for cancer immunotherapyon February 19, 2020 at 12:47 pm
1 Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA. 2 Institute of Engineering in Medicine, University of California San Diego, La Jolla, CA 92093, USA. ↵* ...
- Controlling CAR T cells with light selectively destroys skin tumors in miceon February 19, 2020 at 11:47 am
... very difficult to identify an ideal antigen for solid tumors with high specificity so that CAR T cells only target these diseased tumor sites without attacking normal organs and tissues," said ...
- New insight into how stem cells interact with breast cancer cellson February 18, 2020 at 4:44 am
Mj has published her findings in the Bioengineering journal in a paper titled "Determining Conditions for Successful Culture of Multi-Cellular 3-D Tumour Spheroids to Investigate the Effect of ...
- Organ-specific signature profiles for blood vessel cellson February 15, 2020 at 6:52 am
pharmacology and bioengineering at the College of Medicine. Similar results were found for heart endothelial cells, which expressed the genes known to help heart muscle cells beat and pump blood. "We ...
- Mending a broken heart -- the bioengineering wayon February 13, 2020 at 9:43 am
Cardiac patches lined with heart cells can be applied surgically to restore heart ... Michael Monaghan, ussher assistant professor in biomedical engineering at Trinity, and senior author on the paper, ...
- Tension in tumour cells keeps metabolism highon February 12, 2020 at 10:05 am
Valerie M. Weaver is in the Department of Surgery and the Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, San Francisco, California 94143, USA. Cells sense ...
via Bing News